XINCAT
Zibo
About XINCAT
XINCAT is a pharmaceutical manufacturing company that provides antibiotics, capsules, granules, and sustained-release tablets. Their products such as cefaclor capsules, cefaclor granules, glipizide capsules, pioglitazone hydrochloride capsules, cefuroxime axetil dispersible tablets, cefaclor sustained release tablets, loratadine hydrochloride capsules, compound paracetamol dispersible tablets, finasteride capsules, and cefixime capsules.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Total funding: $475.4K
- Funding stage: Seed
- Last round: Angel (Mar 2012)
- Website: xincat.com.cn
- Phone: 800-860-1660
Industries & Categories
Chemical, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/xincat-3312558 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.